Long-term Safety Study of Vildagliptin in Patients With Type 2 Diabetes

Clinical trial NCT01159249 · COMPLETED

Trial details

NCT number: NCT01159249
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2010-06-01
Primary completion: 2012-01-01
Enrollment: 245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.